Out-licensing

A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More

Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More

Methods and assays which may be used to diagnose and follow the progression of cancers associated with c-Met expression More

The most desirable feature of this new compound is its ability to specifically inhibit O-GlcNAcase without targeting the related hexosaminidase A (HEX A) and hexoaminidase B (HEX B) enzymes. More

A mechanism for augmenting the immune response against HEV in infected individuals More

Identification of three genetic markers in the ABCB1 gene that can be used to predict the degree of neutropenia and peripheral neuropathy that an individual will experience following paclitaxel treatment More

Compositions and methods for detecting the presence of marinobufagenin in a biological sample More

Scientists at NIH have identified a genetic marker called CYP1B1*3 (4326C>G; L432V) that can predict survival in patients with prostate cancer prior to treatment with docetaxel. This genetic marker can be measured in DNA obtained from a blood sample. More